Sema4 announced Tuesday the AI-backed genomic and clinical data company was laying off around 250 workers, about 13% of its workforce, as part of a larger restructuring.
Combined with earlier layoffs from the first half of the year, Sema4 said it has cut approximately 30% of the jobs from its legacy business.
Additionally, founder Eric Schadt is stepping down from his roles as president and...
Mental health EHR Osmind scored $40 million in a Series B funding round led by DFJ Growth.
Other participants include Susa Ventures, General Catalyst, Future Ventures, Tiger Global, Pear VC and angels Lachy Groom, Brent Saunders, Helena Goodman and Ariel Katz.
Osmind offers an EHR tailored to clinicians and researchers using and studying ketamine and other psychedelics, as well as transcranial...
Element5, which offers software to post-acute care facilities to help automate administrative tasks, announced Tuesday it had scooped up $30 million in a Series B funding round led by Insight Partners.
The company said the latest round brings its total raise to $48.5 million. Its $15 million Series A was announced less than a year ago in August. Element5 said the funds will go toward increasing...
Drug discovery startup ArrePath announced Thursday it has raised $20 million in a seed funding round led by the Boehringer Ingelheim Venture Fund, Insight Partners and Innospark Ventures.
Other participants in the round include Viva BioInnovator, Arimed Capital, PTX Capital and Nor’easter Ventures. The company, which focuses on developing new types of anti-infective drugs to best antimicrobial...
Viome Life Sciences announced Wednesday it had raised $54 million in a pre-Series C convertible funding round.
Participants in the round include existing investors Khosla Ventures, West River Group, Glico, Physician Partners and Bold Capital Group alongside new investor Ocgrow Ventures.
Viome said this latest investment brings its total capitalization to $125 million.
WHAT THEY DO
Viome is split...
GE will spin off its healthcare division, GE Healthcare, in early 2023 as part of a larger effort to separate the nearly 130 year old industrial giant into three separate public companies.
GE plans to retain a stake of 19.9% in GE Healthcare once it’s spun off. The conglomerate will also combine its renewable energy, power and digital businesses and spin them off in early 2024, leaving the...
PathAI, maker of AI-enabled pathology products, announced Friday it was partnering with pharma and diagnostics giant Roche.
The strategic partnership will allow PathAI to develop and distribute its AI pathology tech through Roche’s uPath enterprise software, a workflow platform for labs.
The collaboration will begin with distributing PathAI’s research-use-only algorithms through the cloud...
Dutch health tech company Royal Philips today introduced its new enterprise-wide digital pathology platform called IntelliSite.
The product features a suite of scalable software tools designed to streamline workflows, enhance diagnostic confidence, facilitate collaboration, integrate artificial intelligence (AI) and increase the efficiency of pathology labs, Philips said in its announcement....
Delphinus Medical Technologies, a Novi, Michigan-based medical imaging company, today announced the U.S. Food and Drug Administration has given its breast cancer-screening ultrasound device premarket approval.
The SoftVue 3D Whole Breast Ultrasound Tomography System is intended to be used in addition to digital mammograms to screen for breast cancer among patients with dense breast tissue....
CGBIO, a regenerative medicine company in South Korea, and NDR Medical Technology, a Singaporean AI medical device maker, have joined hands to introduce an AI robotic intervention device through upcoming clinical studies.
WHAT IT'S ABOUT
Founded in 2015, NDR Medical Technology has developed what could be the world's first patented automated needle targeting (ANT) system that facilitates safe and...